This suggests that nNOS may confer cardioprotective effects by regulating the S-nitrosylation of Ca2+ handling proteins and inhibiting L-type Ca2+ channel activity, thus reducing the risk of ventricular arrhythmias and mortality following myocardial infarction. The gene discussed is NOS1; the disease is Ventricular arrhythmia.